News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories
Event Calendar

Spotlight -

Concierge Medicine Forum|

News|Videos|May 20, 2025

Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?

Author(s)Richard Payerchin

Fact checked by: Todd Shryock

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

GLP-1 RA drugs have made headlines for improving health — and for high costs. Compounded versions may be less expensive, but that is not the case with every drug. Scott Brunner, CAE, CEO of the Alliance for Pharmacy Compounding, explains the context of cost for compounded medicines.

Newsletter

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Related Content

Karl Storz partners with Moon Surgical and Sovato for open robotic surgery ecosystem: ©Karl Storz

Karl Storz partners with Moon Surgical, Sovato to build open robotic surgery ecosystem

July 22nd 2026

Cost is the wrong way to judge medical AI, physicians argue © InfiniteFlow - stock.adobe.com

Cost is the wrong way to judge medical AI, physicians argue

ByAustin Littrell

July 22nd 2026

Accountable care organization leaders detail wins, and unfinished business, in Medicare reform

ByRichard Payerchin

July 22nd 2026

9 ways to trim overhead without cutting patient care © Luther - stock.adobe.com

9 ways to trim overhead without cutting patient care

ByAustin Littrell

July 22nd 2026

Fugitive arrested in $547M Medicare fraud; pregnancy complications tied to artery disease; swimming eases back pain — Morning Medical Update © everythingpossible - stock.adobe.com

Fugitive arrested in $547M Medicare fraud; pregnancy complications tied to artery disease; swimming eases back pain — Morning Medical Update

ByAustin Littrell

July 22nd 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

Who's really liable when your AI scribe makes a mistake?

CMS expands health care fraud-fighting efforts as it withholds $1B in Medicaid funds

Heading into the midterms, voters blame doctors and hospitals for most Medicare and Medicaid fraud, KFF poll finds

Inside CMS's push to rebalance Medicare payments toward primary care

Fugitive arrested in $547M Medicare fraud; pregnancy complications tied to artery disease; swimming eases back pain — Morning Medical Update